Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

14 projects found matching your search criteria :

  1. Interaction of dopamine receptors with G proteins – structural and kinetic aspects

    Call: OPUS 1 , Panel: NZ1

    Principal investigator: dr Agnieszka Polit

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  2. The effect of imipramine and risperidone on regulation of the chronic mild stress-induced anhedonia and memory impairmen...

    Call: OPUS 5 , Panel: NZ7

    Principal investigator: Mariusz Papp

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  3. In the search for active compounds among ligands of serotonin, particularly 5-HT7, and dopamine receptors, with potentia...

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: prof. Anna Małgorzata Wesołowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  4. Plasticity of glutamatergic synapses on dopamine neurons: the mechanism of habit formation.

    Call: HARMONIA 3 , Panel: NZ4

    Principal investigator: dr hab. Jan Manuel Rodriguez-Parkitna

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  5. Effect of paroxetine and risperidone on the heterodimerization of dopamine D2 and serotonin 5-HT1A receptor in the conte...

    Call: PRELUDIUM 3 , Panel: NZ7

    Principal investigator: dr Magdalena Anna Kolasa

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  6. Search for new "drug-like" molecules designed as adenosine receptors ligands

    Call: HARMONIA 2 , Panel: NZ4

    Principal investigator: prof. Katarzyna Justyna Kieć-Kononowicz

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  7. The role of the mGlu5-D2 heterodimeric receptor complexes in the extinction of drug seeking behavior associated with dep...

    Call: SONATA 2 , Panel: NZ7

    Principal investigator: dr Małgorzata Frankowska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk, Instytut Farmakologii Polskiej Akademii Nauk

  8. Effects of ketamine optical isomers on motivation and decision-making in rats using deep learning for behavioral analysi...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Natalia Alicja Malikowska-Racia

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  9. The interplay of neurochemistry and cancer biology: in the search for novel glioblastoma multiforme therapy among dopami...

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Katarzyna Maria Kucwaj-Brysz

    Uniwersytet Jagielloński, Collegium Medicum

  10. Dopaminergic modulation of high frequency oscillations in the rat olfactory bulb associated with the NMDA receptor hypof...

    Call: PRELUDIUM 20 , Panel: NZ4

    Principal investigator: Jacek Wróbel

    Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polskiej Akademii Nauk

  11. First-in-class dual biased agonists of serotonin 5-HT1A and dopamine D2 receptors – an innovative approach in the search...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Marcin Roman Kołaczkowski

    Uniwersytet Jagielloński, Collegium Medicum

  12. In vivo effects, underlying signaling pathways and mechanism of action of ghrelin receptor agonist against pathological ...

    Call: SONATA 15 , Panel: NZ7

    Principal investigator: dr Piotr Chmielarz

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  13. Characterisation of the orbitofrontal cortex dopamine D1 and D2 receptors' influence on rat's cognitive flexibility and ...

    Call: PRELUDIUM 11 , Panel: NZ4

    Principal investigator: Michał Dariusz Rychlik

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  14. Adaptacyjne podejmowanie decyzji u zwierząt z komórkowo specyficzną inaktywacją receptorów glutaminianu w układzie dopam...

    Call: ETIUDA 4 , Panel: NZ4

    Principal investigator: Przemysław Eligiusz Cieślak

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk